Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 32, Issue 3, 2012, Pages 346-352

  Wu, Shiwu ^a   Yu, Lan ^a   Cheng, Zenong ^a   Song, Wenqing ^a   Zhou, Lei ^a   Tao, Yisheng ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Maspin; Microvessel density; Non small cell lung cancer; Prognosis; Vasculogenic mimicry

Indexed keywords

SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL CULTURE; VASCULARIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SERPINS; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84865608595     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-012-0060-4     Document Type: Article

References (41)

1. Jemal A, Center MM, Desantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 2010,19(8):1893-1907
2. Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin, 2011,61(2):91-112
3. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 1994,263(5146):526-529 (Pubitemid 24082753)
4. Ngamkitidechakul C, Warejcka DJ, Burke JM, et al. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J Biol Chem, 2003,278(34):31796-31806 (Pubitemid 37048361)
5. Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cell. Cancer Biol Ther, 2003,2(4):398-403
6. Liu J, Yin S, Reddy N, et al. Bax mediates the apoptosis- sensitizing effect of maspin. Cancer Res, 2004,64(5): 1703-1711 (Pubitemid 38428692)
7. Zhang W, Shi HY, Zhang M. Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer, 2005,5:50
8. Bailey CM, Khalkhali-Ellis Z, Seftor EA, et al. Biological functions of maspin. J Cell Physiol, 2006,209(3):617 -624 (Pubitemid 44665678)
9. Sheng S. A role of novel serpin maspin in tumor progression: The divergence revealed through efforts to converge. J Cell Physiol, 2006,209(3):631-635 (Pubitemid 44665680)
10. Khalkhali-Ellis Z. Maspin, the new frontier. Clin Cancer Res, 2006,12(24):7279-7283
11. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol, 1999,155(3):739-752 (Pubitemid 29426820)
12. Sood AK, Seftor EA, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol, 2001,158(4):1279-1288 (Pubitemid 32281292)
13. Heyman L, Leroy-Dudal J, Femands J, et al. Mesothelial vitronectin stimulates migration of ovarian cancer cell. Cell Biol Int, 2010,34(5): 493-502
14. Zhao XL, Du J, Zhang SW, et al. A study on vasculogenic mimicry in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi (Chinese), 2006,14(1):41-44
15. Guzman G, Cotler SJ, Lin AY, et al. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med, 2007, 131(12):1776-1781 (Pubitemid 350294576)
16. Liu WB, Xu GL, Ma JL, et al. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma. Tohoku J Exp Med, 2011,224(1):29-39
17. Gray DR, Huss WJ, Yau JM, et al. Short-term human prostate primary xenografts: An in vivo model of human prostate cancer vasculature and angiogenesis. Cancer Res, 2004,64(5):1712-1721 (Pubitemid 38428693)
18. Ahmadi SA, Moinfar M, Gohari Moquaddam K, et al. Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med, 2010,13(6):498-503
19. Fan YZ, Sun W, Zhang WZ, et al. Vasculogenic mimicry in human primary gallbladder carcinoma and clinical significance thereof. Zhonghua Yi Xue Za Zhi, 2007,87(3): 145-149
20. Li M, Gu Y, Zhang Z, et al. Vasculogenic mimicry: A new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res, 2010,16(2):259-266
21. Vartanian AA, Stepanova EV, Gutorov SL, et al. Prognostic significance of periodic acid-schiff-positive patterns in clear cell renal cell carcinoma. Can J Urol, 2009,16(4):4726-4732
22. Shirakawa K, Wakasugi H, Heike Y, et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer, 2002,99(6):821-828 (Pubitemid 34575699)
23. Basu GD, Liang WS, Stephan DA, et al. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cell. Breast Cancer Res, 2006,8(6):R69
24. Yue WY, Chen ZP. Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem, 2005,53(8):997- 1002
25. Kumada T, Tsuneyama K, Hatta H, et al. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: Practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol, 2004,17(9):1141-1149 (Pubitemid 39128241)
26. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS, 2004,112(7-8):508- 525 (Pubitemid 39626057)
27. Toillon RA, Lagadec C, Page A, et al. Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancers through insulin-like growth factor-binding protein-3 and maspin. Mol Cell Proteomics, 2007,6(7):1239-1247 (Pubitemid 47099232)
28. Lonardo F, Li X, Kaplun A, et al. The natural tumor suppressor protein maspin and potential application in nonsmall cell lung cancer. Curr Pharm Des, 2010; 16(16):1877-1881
29. Kim S, Han J, Kim J, et al. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res, 2004,64(19):6900-6905 (Pubitemid 39330997)
30. Nam E, Park C. Maspin suppresses survival of lung cancer cells through modulation of Akt pathway. Cancer Res Treat, 2010,42(1):42-47
31. Takanamil I, Abiko T, Koizumi S, et al. Expression of maspin in non-small-cell lung cancer correlation with clinical features. Clin Lung Cancer, 2008,9(6):361-366
32. Ni JT, Yi YF, Shi HP. Expression of maspin, p53 and Skp2 in colorectal tumors and their clinicopathological significance. Chin J Cancer Res, 2009,21(2):147-153
33. Fan YZ, Sun W. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy. World J Gastrointest Surg, 2010,2(4):117-127
34. Zhang S, Guo H, Zhang D, et al. Microcirculation patterns in different stages of melanoma growth. Onclo Rep, 2006,15(1):15-20
35. Forberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol, 2000, 156(2):361-381 (Pubitemid 30648785)
36. Mineo TC, Ambrogi V, Baldi A, et al. Prognostic impact of VEGF, CD31, CD34 and CD105 expression and tumor vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol, 2004,57(6):591-597 (Pubitemid 38725758)
37. Wang MC, Yang YM, Li XH, et al. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. World J Gastroenterol, 2004,10(5):634-637
38. Sood AK, Fletcher MS, Coffin JE,et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am J Obstet Gynecol, 2004,190(4):899-909 (Pubitemid 38561505)
39. Sun B, Zhang S, Zhao X, et al. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol, 2004,25(6):1609-1614
40. Wang W, Lin P, Han CH, et al. Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res, 2010, 29:60
41. Nakashima M, Ohike N, Nagasaki K, et al. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol, 2004,130(8):475-479 (Pubitemid 39119291)